| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.36 | 0.02 |